Display Settings:

Format

Send to:

Choose Destination

    J Am Acad Dermatol. 1996 Feb;34(2 Pt 2):365-7.

    Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis.

    Webster GF, Knobler RL, Lublin FD, Kramer EM, Hochman LR.

    Department of Dermatology, Jefferson Medical College, Philadelphia, USA.

    Erratum in:

    • J Am Acad Dermatol 1996 Oct;35(4):587.

    Comment in:

    Seven patients with multiple sclerosis who were receiving subcutaneous injections of recombinant interferon beta had pain followed by ulceration at the injection site. An eighth patient had a pustular flare of her usually mild psoriasis. No evidence of infection or contaminated medication was found.

    PMID: 8655728 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information

    • Interferon Beta-1b Injection (Betaseron®)

      Your doctor has ordered interferon beta-1b, a biologic response modifier. This medication is used to treat patients with multiple sclerosis (MS), a disease in which the nerves do not function properly and patients may ex...

    • Interferon beta-1a Subcutaneous Injection (Rebif®)

      Interferon beta-1a is used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis (MS, a disease in which the nerves do not function properly and pa...